| There are no translations available.
- MédiMabs facilitates research by adding new tools to address specific antibody needs.
- MédiMabs conducts joint R&D projects based on the concept of shared intellectual rights.
- MédiMabs is dedicated to providing the researcher with the largest choice of antibodies based on the most innovative licensing agreement in the industry.
- MédiMabs is self-sufficient, giving end users the highest quality antibodies and the speediest delivery time in the industry.
- MédiMabs offers extensive customer service and technical support which include new proprietary affordable humanization services.
|
| Mise à jour le Jeudi, 15 Septembre 2011 20:48 |
